Structural insights into the modes of relaxin-binding and tethered-agonist activation of RXFP1 and RXFP2
A. Sethi, S. Bruell, T. Ryan, F. Yan, M. H. Tanipour, Y. F. Mok, C. D. Joyce, Y. Khandokar, R. D. Metcalfe, M. D. W. Griffin, D. J. Scott, M. A. Hossain, E. J. Petrie, R. A. D. Bathgate, P. R. Gooley
Abstract
Our poor understanding of the mechanism by which the peptide-hormone H2 relaxin activates its G protein coupled receptor, RXFP1 and the related receptor RXFP2, has hindered progress in its therapeutic development. Both receptors possess large ectodomains, which bind H2 relaxin, and contain an N-terminal LDLa module that is essential for receptor signalling and postulated to be a tethered agonist. Here, we show that a conserved motif (GDxxGWxxxF), C-terminal to the LDLa, is critical for receptor activity. Importantly, this motif adopts different structures in RXFP1 and RXFP2, suggesting distinct activation mechanisms. For RXFP1, the motif is flexible, weakly associates with the LDLa, and requires H2 relaxin binding to stabilize an active conformation. Conversely, the GDxxGWxxxF motif in RXFP2 is more closely associated with the LDLa, forming an essential binding interface for H2 relaxin. These differences in the activation mechanism will aid drug development targeting these receptors.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Divergent activation of the RXFP1 relaxin receptor by protein and small molecule agonists
James Osei‐Owusu, Tristan Girbau, … Andrew C. Kruse·bioRxiv·Jun 11, 2026
- The relaxin receptor RXFP1 signals through a mechanism of autoinhibition
S. C. Erlandson, S. Rawson, … A. C. Kruse·bioRxiv·Jan 22, 2022
- A complete RXFP1-relaxin interaction model unlocks the design of potent mini-protein modulators
Janik Clément, Tim Lkhagvajargal, … Rhys Grinter·bioRxiv·Jun 22, 2026
- Engineering and characterization of a long half-life relaxin receptor RXFP1 agonist
S. C. Erlandson, J. Wang, … A. C. Kruse·bioRxiv·Apr 19, 2022
- Structural and Functional Diversity among Agonist-Bound States of the GLP-1 Receptor
B. P. Cary, P. Zhao, … S. H. Gellman·bioRxiv·Feb 24, 2021
- A unique peptide recognition mechanism by the human relaxin family peptide receptor 4 (RXFP4)
Yan Chen, Qingtong Zhou, … Ming‐Wei Wang·bioRxiv·Jul 28, 2022